FDA Warning Letter — Prescription Lab Compounding Pharmacy
The FDA took a Warning Letter action against Prescription Lab Compounding Pharmacy on November 16, 2016 (Tucson, AZ). The action was issued by CDER and concerns drugs products. This facility has 1 recent FDA inspection on record.
Action Details
- Facility
- Prescription Lab Compounding Pharmacy
- Date
- November 16, 2016
- Fiscal Year
- 2017
- Product Type
- Drugs
- Center
- CDER
- Location
- Tucson, AZ (United States)